Samalizumab
Samalizumab Basic information
- Product Name:
- Samalizumab
- Synonyms:
-
- Samalizumab
- Research Grade Samalizumab (DHE30301)
- Research Grade Samalizumab
- Samalizumab (anti-CD200)
- CAS:
- 1073059-33-2
- MW:
- 0
- Mol File:
- Mol File
More
Less
Samalizumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Samalizumab Usage And Synthesis
Uses
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research[1].
References
[1] Daruka Mahadevan, et al. Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200. J Immunother Cancer. 2019 Aug 23;7(1):227. DOI:10.1186/s40425-019-0710-1
SamalizumabSupplier
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
ShangHai Biochempartner Co.,Ltd
- Tel
- 177-54423994 17754423994
- 2853530910@QQ.com
Nanjing Leon Biological Technology Co., Ltd.
- Tel
- 17705183659
- sales@njleonbiotech.com
Nanjing Peptide Biotech Ltd.
- Tel
- 025-58361106-805 15951641583
- zhao.xu@njpeptide.com
Nanjing Meihao Pharmaceutical Technology Co., Ltd.
- Tel
- meitaochem@126.com
- meitaochem@126.com